Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.34% | 182.46 | 0.0% | $886.10m | |
| AMGN | Amgen, Inc. | -0.09% | 246.04 | 1.5% | $591.52m | |
| NVAX | Novavax, Inc. | -3.49% | 58.17 | 75.7% | $445.72m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.64% | 292.74 | 1.9% | $426.74m | |
| GILD | Gilead Sciences, Inc. | 0.66% | 61.49 | 1.0% | $374.72m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.30% | 627.69 | 2.6% | $352.35m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 3.87 | 0.7% | $270.53m | |
| ILMN | Illumina, Inc. | -0.33% | 223.04 | 3.3% | $240.74m | |
| BIIB | Biogen, Inc. | -0.37% | 217.39 | 1.8% | $200.48m | |
| GOVX | GeoVax Labs, Inc. | -10.16% | 2.89 | 0.0% | $143.97m | |
| BNTX | BioNTech SE | -9.87% | 165.03 | 0.0% | $138.17m | |
| CRSP | CRISPR Therapeutics AG | 0.08% | 81.47 | 0.6% | $132.88m | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 5.02% | 21.26 | 0.0% | $95.89m | |
| PLRX | Pliant Therapeutics, Inc. | -0.11% | 18.89 | 0.0% | $95.31m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.63% | 95.22 | 4.2% | $94.74m |
Company Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.